Clinical Trial Update: BHB & CAR-T for Lymphomas [NA]

View source ↗

Summary

A ClinicalTrials.gov update notes recruitment for a study evaluating beta-hydroxybutyrate (BHB) in combination with CAR-T therapy for Large B-cell Lymphoma. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• BHB (beta-hydroxybutyrate)
• CAR-T therapy (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Large B-cell Lymphoma | NA | Status: RECRUITING